US Airways Is on a ...
Health Care: Drugs
Catalyst Pharmaceutical Partners Inc. (CPRX: NASDAQ)
$0.91 0.05 | 5.68%
05/21/13 - 03:58 PM ET
Company Income Statement
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Sales | 0.00 | 0.00 | 488.96K | 0.00 |
| Cost of Sales | 0.00 | 0.00 | 0.00 | -30.23K |
| Gross Operating Profit | 0.00 | 0.00 | 488.96K | 30.23K |
| Selling, General, and Administrative Expenses | 2.56M | 2.70M | 2.21M | 2.18M |
| Research & Development | 2.66M | 3.38M | 2.31M | 5.10M |
| Operating Income before D & A (EBITDA) | -5.22M | -6.08M | -4.02M | -7.25M |
| Depreciation & Amortization | 10.89K | 42.84K | 25.74K | 30.23K |
| Interest Income | 14.98K | 10.98K | 17.86K | 33.47K |
| Other Income - Net | 1.13M | -319.91K | 0.00 | 0.00 |
| Special Income / Charges | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Income Before Interest Expenses (EBIT) | -4.09M | -6.43M | -4.03M | -7.24M |
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 |
| Pre-Tax Income | -4.09M | -6.43M | -4.03M | -7.24M |
| Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Continuing Operations | -4.08M | -6.39M | -4.01M | -7.24M |
| Net Income From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Total Operations | -4.08M | -6.39M | -4.01M | -7.24M |
| Extraordinary Income/Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Cum. Effect of Acct. Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Tax Loss Carryforward | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Net Income | -4.08M | -6.39M | -4.01M | -7.24M |
| Normalized Income (Net Income From Continuing Operations, Ex. Special Income / Charge) |
-4.08M | -6.39M | -4.01M | -7.24M |
| Preferred Dividends | ||||
|---|---|---|---|---|
| Net Income Available To Common | -4.08M | -6.39M | -4.01M | -7.24M |
| Basic EPS from Continuing Ops. | -0.14 | -0.29 | -0.22 | -0.48 |
| Basic EPS from Discontinued Ops. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Total Operations | -0.14 | -0.29 | -0.22 | -0.48 |
| Basic EPS from Extraordinary Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Tax Loss Carryf'd. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Other Gains (Losses) | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS, Total | -0.14 | -0.29 | -0.22 | -0.48 |
| Basic Normalized Net Income/Share | -0.14 | -0.29 | -0.22 | -0.48 |
| EPS fr Continuing Ops. | -0.14 | -0.29 | -0.22 | -0.48 |
| EPS fr Discontinued Ops | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Total Ops. | -0.14 | -0.29 | -0.22 | -0.48 |
| EPS fr Extraord. Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Tax Loss Carfd. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Other Gains (L) | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS, Total | -0.14 | -0.29 | -0.22 | -0.48 |
| Diluted Normalized Net Inc/Shr (Net Income From Continuing Operations, Ex. Special Income / Charge) |
-0.14 | -0.29 | -0.22 | -0.48 |
| Dividends Paid per Share | 0.00 | 0.00 | 0.00 | 0.00 |
Portfolios with CPRX
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks With Big Insider Buy...
- UserWatch
- ContributorStocks Under-$10 Setting Up...
- UserStan/Gino
- ContributorStocks Under-$10 Moving Hig...
- UserBiotech88
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Under-$10 Moving Hig...
- ContributorBreakout Stocks Of The Week...
Latest CPRX Headlines from TheStreet
- Catalyst Pharmaceutical Partners Reports Fourth Quarter And Year-End 2012 Financial Results 04.02.13 | 08:04 am
- Catalyst Pharmaceutical Partners Announces Recommendation Of Data Monitoring Committee For Pivotal Phase Lll Clinical Trial For Firdapse(TM) 03.27.13 | 08:03 am
- Catalyst Pharmaceutical Partners To Present At 25th Annual ROTH Conference 03.07.13 | 08:03 am
- Catalyst Pharmaceutical Partners Appoints Dr. Bernardino Mosquera As Vice President Of Clinical Operations 03.05.13 | 08:03 am
- Catalyst Pharmaceutical Partners Launches New Website 02.21.13 | 08:02 am
- Catalyst Pharmaceutical Partners Provides Update On Research And Development Pipeline 02.11.13 | 08:02 am
- 3 Biotech Stocks Under $5 Moving Higher 02.07.13 | 02:02 pm
- Catalyst Pharmaceutical Partners To Present At 15th Annual BIO CEO & Investor Conference 02.05.13 | 08:02 am
- Catalyst Receives Guidance From NASDAQ Regarding Minimum Bid Price Requirement 12.27.12 | 08:12 am
- 5 Stock Insiders are Gobbling Up 12.19.12 | 12:12 pm
Press Releases for CPRX
- The Market Slips Lower And EBay Falls On Earnings Outlook - PR Newswire 04.19.13 | 07:04 am
- Vigabatrin/CPP-109 Data To Be Presented At College On Problems Of Drug Dependence Annual Meeting - PR Newswire 06.09.10 | 08:06 am
- Catalyst Pharmaceutical Partners To Present At The MoneyShow Conference - PR Newswire 05.07.10 | 08:05 am
- Catalyst Pharmaceutical Partners Regains Compliance With NASDAQ Minimum Bid Price Rule - PR Newswire 04.26.10 | 11:04 am
- Catalyst Pharmaceutical Partners Signs Definitive Agreement With The National Institute On Drug Abuse To Conduct U.S. Phase II(B) Clinical Trial For Cocaine Addiction - PR Newswire 04.13.10 | 10:04 am
- CPP-109 Clinical Trial Data To Be Presented At The American Society Of Addiction Medicine Annual Medical-Scientific Conference - PR Newswire 04.09.10 | 08:04 am
- Catalyst Pharmaceutical Partners Reports Fourth Quarter And Year-End 2009 Financial Results - PR Newswire 04.01.10 | 08:04 am
- Catalyst Pharmaceutical Partners To Present At The BioNetwork East 2010 Conference - PR Newswire 03.10.10 | 08:03 am
- Catalyst Pharmaceutical Partners To Present Today At 2010 Epilepsy Pipeline Update Conference - PR Newswire 02.25.10 | 08:02 am
- Catalyst Pharmaceutical Partners And The National Institute On Drug Abuse Plan To Initiate U.S. Phase II(b) Clinical Trial For Cocaine Addiction - PR Newswire 02.23.10 | 08:02 am
Partner Headlines for CPRX
- Zacks #1 Rank Additions for Wednesday - Tale of the Tape - Zacks 11.07.12 | 09:11 am
- Morning Market Losers - Benzinga 09.26.12 | 09:09 am
- Under Construction Rehash: Buy Acadia And Astex - Seeking Alpha 09.20.12 | 09:09 am
- Weekly CFO Buys Highlight: CPRX, APPY, MEI, MNKD - GuruFocus 07.09.12 | 01:07 pm
- Weekly CFO Buys Highlight: EMC, DVOX, NANX, CPRX, CCRN - GuruFocus 06.04.12 | 01:06 pm
- 7 Stocks Under $6 Poised To Double In 2012 - Seeking Alpha 11.24.11 | 06:11 am
- 6 Biotechs That Could See Huge Gains (Like Inhibitex) - Seeking Alpha 11.11.11 | 09:11 am
- Zacks #1 Rank Additions for Friday - Tale of the Tape - Zacks 10.14.11 | 09:10 am
- Zacks #1 Rank Additions for Monday - Tale of the Tape - Zacks 10.10.11 | 09:10 am
- Morning Market Losers - Benzinga 06.06.11 | 09:06 am
